Tender notice from Bulgaria, published on 10 Jan 2019.
Executive Summary
The „?????????? ??????????? ?????? — ?????? ???????“ ???? has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Bulgaria. This Tender notice was published on 10 Jan 2019 and is scheduled to close on 13 Feb 2019, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 29743972, while the tender notice number is 011170-2019 and Register on the platform.
Object of the contract Pharmaceutical products Description: Contract notice: Pharmaceutical products Authority Type: Other Contact Nature: Supplies Procedure: Open procedure Document: Contract notice Regulation: European Union Award criteria: Lowest price CPV code: 33600000, 33600000, 33600000 CPV Description: Pharmaceutical products Supply of medicines for the needs of "KOT - V. Tarnovo" EOOD Reference Number: 00763 Supply of medicines for treatment of patients with oncological diseases in "KOT - V. Tarnovo" Ltd. Main Site: Hospital pharmacy of "KOTS - V.Tarnovo" Ltd. - Delivery of medicinal products with a total of 77 nomenclature units, by name, pharmaceutical form and forecastичество, както следва: Sevofluran — fl 250 ml 200; Fentanyl — 0, 05 mg/ml, 2ml 500; Fentanyl — аmp 0, 05 mg/ml 5 ml 1 300; Propofol — amp 10 mg/ml, 20 ml 900; Rоpivacaine — fl.7, 5 mg/ml 10 ml 200; Levobupivacaine — amp. 5mg/ml 50; Еtomidate — amp. 20 mg/10 ml 100; Paracetamol — fl. 10 mg/ml 100 ml 400; Vitamin B1 — B6 — B12 — Dr/caps 3 000; Potassium chloride — 14, 9 ml 3 000; Magnesium DL — aspartate/ Potassium DL—aspartate tb. 200; Alanyl glutamine — fl. 100 ml 50; Nadroparin — 0, 8 ml. 200; Fegluconat Mn gluconat Copper gluconat — amp. 10 ml 3 000; Aminoacids — fl. 500 мл. 10 % 2 000; Aminoacids N Heppa — fl. 500 ml 8 % 50; Glucosa 150g Amino acid 51g Lipidi 60g — central — 1 540 ml 500; Glucosa 37 g Amino acid 34g Lipidi 51g — peripheral — 1 440 ml. 500; Fat emulsions — 10 % 500 ml. 2 000; Water for injection - 500 ml. 2, 000; Colloidal plasma volume dispenser - 500 ml. 200; Digoxin - tb. 0.25 mg 50% Propafenone - 150 mg. 100; Verapamil Hydrochloride - tb.40mg, . 200; - Losartan - 50 mg., 200; - Bisoprolol hemifumarate - tb.5 mg. 200; Atenolol - tb.25 mg 200; Metoprolol tartrate - tb.50mg .. 100; Carvediol - tb.12.5mg. 100; Diltiazem - 60 mg. 100; Isosorbite dinitrate -tb.20mg. 200; Glyceryl trinitrate — spray 10; Glyceryl trinitrate — fl.50mg 50ml 200; Furosemide — tab 40 mg. 600; Torasemide — 10mg. 2 ml 200; Torasemide — tb.10 mg. 200; Vaselinum album — ungv. kг. 5; Polyvidonum cum iodo — ungv. 300; Sulfadiazinum argenticum — 1 %, 50 gr.tuba 30; Glicerinum — 1 000 ml. 3; Ricini oleum — 1 000 ml. 50; Prednisolone — tb. 5 mg., 1 000; Prednisone — tb. 5 mg., 600; Somatostatin — amp. 0, 25 mg. 50; Somatostatin — amp. 3 mg. 50; Doxycycline — caps. 100 mg. 60; Sultamicillin — tb. 375 mg. 300; Amoxicillin — caps. 1 000 mg. 300; Piperacillin — fl. 2, 0 gr 100; Clarithromycin — fl. 500 mg, 100; Azithromycin — pulv. 2g 50; Clindamycin — tb. 600 mg. 800; Lincomycin — fl. 600 mg 300; Lincomycin — caps. 500 mg. 200; Tobramycin — fl. 80 mg—2ml 100; Baneocyn — pulvis200; Daptomycin — fl. 500mg 50; Chloramphenicol — 250 mg caps 600; Colistimethate sodium — fl 1 MIU 100; Moxifloxacin — tb. 400 mg 100; Metronidazole — tb.250 mg. 400; Metronidazole — tb.500 mg. 100; Nimesulid — Tb. 100 mg. 100; Rocuronium bromide sol. for ing — amp. 10 mg/ml — 5ml. 200; Ephedrinum — amp. 50mg/1ml 100; Urogafin — 76 % 20 ml. amp. 60; Iohexol — amp. 350mg./ 50ml. 2 000; Стандартнаenriched food containing - proteins, carbohydrates and fiber 200 ml 1000 - standard enteral feed containing - proteins, carbohydrates and fiber 500 ml 500 - dietary protein for diabetics - proteins, carbohydrates and fibers 200 ml 500 - oligopeptide low molecular food for probe Feeding 500 ml 50 - Enteral feed with immunomodulating action for sonic feeding 500 ml 50 - Blood group blood test. 10 ml. 100; Calcitonin / salmon synthetic / -amp. 50 IU / ml. 20; Flumazenil amp; 0.1 mg / ml 5 ml 20% Flumazenil amp; 0.1 mg / ml 10 ml 20; Granisetron tb. 2 mg - tb. 2 mg 1, 800.- The participants have a valid permit for wholesale trade with medicinal products issued by the BDA on the basis of LMPHM and for the foreign persons an equivalent document according to their national legislationIn order to prove eligibility criteria, participants on request, and the contractor selected before the contract is concluded, shall present a valid authorization to carry out wholesale trade in medicinal products or an equivalent document in accordance with the legislation of the country in which the participant is established for foreign participants.) Not applicable For participants in Prothe circumstance under Art. 54 and Art. 55, para. 1, item 1 of the Public Procurement Act. Otherwise, they are removed from participation. They shall declare the lack of grounds for removal under Art. 54 and Art. 55, para. 1, item 1 of the Public Procurement Act through the presentation of the eEEDOP when submitting its tender. In the event that the participant has the circumstance under Art. 55, para. 1, item 1 of the Public Procurement Act, it may not be correctedif it is proved that it has not ceased its activity and is able to execute the order. Existence or absence of the circumstances for removal under Art.159a-159d, Art. 192 a, Art. 209, Art. 253, Art. 301-307, Art. 321 and 321a of the Criminal Code are declared in section A "Grounds relating to criminal convictions" in Part III "Grounds for exclusion" in the enEEDOP. The existence or absence of circumstances forsuspension under Art. 108a, Art. 172, Art. 194-217, Art. 219-252, Art. 352-353 is, Art. 254-260 of the Penal Code is declared in Part D "Other grounds for exclusion that may be provided for in the national law of the contracting authority or the contracting authority of a Member State" in Part III "Grounds for exclusion" in the EDEDDO. The performance guarantee is 2% of the contract value excluding VAT. The same is presented inone of the forms under Art. 111, para. 5 of the Public Procurement Act. Bank Guarantee and Insurance have a validity of one month after the term of the contract, and the monetary guarantee is deposited on the following bank account: IBAN BG 52 UNCR 9660 10 37 299 411 BIC: UNCRBGSF, Unicredit Bulbank AD, Veliko Tarnovo Branch. The conditions for the release of the performance guarantee shall be laid down in the contract for the award of the contractthis order shall be subject to the reverse order in consideration of the tenders, in accordance with Art. 104, para. 2 of the Public Procurement Act and Art. 61 of the PPP Internet address (URL): www.onkologyvt.com
The bid deadline for Contract notice: Pharmaceutical products was 13 Feb 2019. Bidding is closed.
This tender has been issued by „?????????? ??????????? ?????? — ?????? ???????“ ???? in Bulgaria.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is Self Financed
The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 29743972. The purchaser document reference is 011170-2019.